(Q80385282)

English

Thiazolidinedione therapy gets complicated: is bone loss the price of improved insulin resistance?

scientific article published on 01 June 2007

In more languages

default values for all languages

No label defined

No description defined

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17526825

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17526825%20AND%20SRC:MED&resulttype=core&format=json

retrieved

31 December 2019

editorial

0 references

title

Thiazolidinedione therapy gets complicated: is bone loss the price of improved insulin resistance? (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17526825

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17526825%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference

1

Ann V Schwartz

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17526825

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17526825%20AND%20SRC:MED&resulttype=core&format=json

retrieved

31 December 2019

author name string

Deborah E Sellmeyer

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17526825

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17526825%20AND%20SRC:MED&resulttype=core&format=json

retrieved

31 December 2019

language of work or name

English

0 references

publication date

1 June 2007

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17526825

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17526825%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference

Europe PubMed Central

PubMed publication ID

17526825

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17526825%20AND%20SRC:MED&resulttype=core&format=json

retrieved

31 December 2019

volume

30

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17526825

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17526825%20AND%20SRC:MED&resulttype=core&format=json

retrieved

31 December 2019

issue

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17526825

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17526825%20AND%20SRC:MED&resulttype=core&format=json

retrieved

31 December 2019

page(s)

1670-1671

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17526825

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17526825%20AND%20SRC:MED&resulttype=core&format=json

retrieved

31 December 2019

Identifiers

DOI

10.2337/DC07-0554

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17526825

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17526825%20AND%20SRC:MED&resulttype=core&format=json

retrieved

31 December 2019

PubMed publication ID

17526825

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17526825

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17526825%20AND%20SRC:MED&resulttype=core&format=json

(Q80385282)

Thiazolidinedione therapy gets complicated: is bone loss the price of improved insulin resistance?

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)